1LBA Everolimus plus exemestane for hormone receptor-positive (HR+), human epidermal growth factor receptor-2-negative (HER2–) advanced breast cancer (BC): overall survival results from BOLERO-2

✍ Scribed by Piccart, M.; Hortobagyi, G.N.; Campone, M.; Pritchard, K.I.; Noguchi, S.; Rugo, H.; Gnant, M.; Feng, W.; Taran, T.; Baselga, J.

• Book ID: 122174898
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 46 KB
• Volume: 50
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(14)00221-4